Study Phase | Phase 4 |
Therapeutic Area | Oncology |
Active Substance | TIPIRACILTRIFLURIDINETRIFLURIDINE - TIPIRACIL |
Sponsor | Servier Deutschland GmbH |
Active Substance Code | S095005 |
Protocol Code | IC4-95005-183-DEU |
EudraCT Code | 2017-000292-83 |
ISRCTN Code | ISRCTN90009147 |
Tallisur : | DRKS00012977 |
Results are not yet available. |
To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.